Cephalalgia

Cover image for Vol. 29 Issue s2

Special Issue: Tonabersat, a Novel Gap-Junction Modulator for the Prevention of Migraine

November 2009

Volume 29, Issue Supplement s2

Pages 1–35

  1. Tonabersat, a Novel Gap-Junction Modulator for the Prevention of Migraine

    1. Top of page
    2. Tonabersat, a Novel Gap-Junction Modulator for the Prevention of Migraine
    1. Minster Pharmaceuticals provided financial support for this supplement

    2. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine (pages 17–27)

      SD Silberstein, J Schoenen, H Göbel, HC Diener, AH Elkind, JA Klapper and RA Howard

      Version of Record online: 1 SEP 2009 | DOI: 10.1111/j.1468-2982.2009.01974.x

    3. Tonabersat, a novel gap-junction modulator for the prevention of migraine (pages 28–35)

      SD Silberstein

      Version of Record online: 1 SEP 2009 | DOI: 10.1111/j.1468-2982.2009.01973.x

SEARCH

SEARCH BY CITATION